Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Astellas Venture Management

Astellas Venture Management

A Menlo Park-based venture capital firm that invests in companies within the biotechnology sector

Astellas Venture Management is a venture capital firm in Menlo Park that prefers to invest in companies within the biotechnology sector. Founded 1999 in Menlo Park, California, the firm invests in early stage ventures, late stage ventures, and private equity. The notable investment portfolio of Astellas Venture Management includes TScan Therapeutics, Heartseed, CODA Biotherapeutics, Oncorus, Cleave Therapeutics, Twentyeight-Seven Therapeutics, Effector Therapeutics, and Oncorus. As of January 2020, Astellas Venture Management has made 41 investments and 9 exits. Their most recent investment was on Jan 10, 2020, when TScan Therapeutics raised $35M.

Timeline

1999
Founded

Invested in

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Mark Terry
May 5, 2021
BioSpace
There's money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here's a look.
NeoPhore
March 9, 2021
www.prnewswire.com:443
/PRNewswire/ -- NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces the close of a £15.2m (US $21m) Series B round. The...

References

Golden logo
By using this site, you agree to our Terms & Conditions.